Skip to main content
SpringerLink
Log in

ATP10B and the risk for Parkinson’s disease

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrøm L et al (2019) Parkinson’s disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms. Mov Disord 34:866–875

    Article  CAS  Google Scholar 

  2. Martin S, Smolders S, Van den Haute C, Heeman B, van Veen S, Crosiers D et al (2020) Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export. Acta Neuropathol. https://doi.org/10.1007/s00401-020-02145-7

    Article  PubMed  PubMed Central  Google Scholar 

  3. Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18:1091–1102

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported in part by the Intramural Research Programs of the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging (NIA), and the National Institute of Environmental Health Sciences both part of the National Institutes of Health, Department of Health and Human Services; project numbers 1ZIA-NS003154, Z01-AG000949-02 and Z01-ES101986. In addition, this work was supported by the Department of Defense (award W81XWH-09-2-0128), and The Michael J Fox Foundation for Parkinson’s Research. Data used in the preparation of this article were obtained from the AMP PD Knowledge Platform. For up-to-date information on the study, visit https://www.amp-pd.org. AMP PD—a public-private partnership—is managed by the FNIH and funded by Celgene, GSK, the Michael J. Fox Foundation for Parkinson’s Research, the National Institute of Neurological Disorders and Stroke, Pfizer, and Verily. RR is funded by a Walker-Peltz Fellowship.

Author information

Authors and Affiliations

  1. Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK

    Raquel Real & Huw R. Morris

  2. UCL Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK

    Raquel Real & Huw R. Morris

  3. Molecular Genetics Section, Laboratory of Neurogenetics, National Institute On Aging, National Institutes of Health, Bethesda, MD, 20892, USA

    Anni Moore, Cornelis Blauwendraat & Sara Bandres-Ciga

Authors
  1. Raquel Real
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anni Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cornelis Blauwendraat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huw R. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sara Bandres-Ciga
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the International Parkinson’s Disease Genomics Consortium (IPDGC)

Corresponding author

Correspondence to Sara Bandres-Ciga.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 350 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Real, R., Moore, A., Blauwendraat, C. et al. ATP10B and the risk for Parkinson’s disease. Acta Neuropathol 140, 401–402 (2020). https://doi.org/10.1007/s00401-020-02172-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-020-02172-4

Search

Navigation